IMR Share Price Performance
AU$0
-1.58 (-100.00%)
Price AU$0
Fair ValueAU$1.91
Share Pricen/a
Imricor Medical Systems, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
IMR Community Narratives
AN
Fair Value AU$1.91 6.1% overvalued intrinsic discount
MRI Electrophysiology Adoption And Regulatory Progress Will Support A Fair Outlook
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value AU$2.7 24.8% undervalued intrinsic discount
MRI Guided Cardiac Ablation Adoption Will Transform Long Term Prospects For This Undervalued Player
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value AU$2.14 5.2% undervalued intrinsic discount
MRI Electrophysiology Adoption And Aging Demographics Will Drive Long Term Earnings Potential
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
MRI Electrophysiology Adoption And Regulatory Progress Will Support A Fair Outlook
Catalysts About Imricor Medical Systems Imricor Medical Systems develops MRI compatible electrophysiology tools and software to enable cardiac ablation procedures inside MRI suites. What are the underlying business or industry changes driving this perspective?Read more
26
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AU$1.91
6.1% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
268.62% p.a.
Profit Margin
9.16%
Future PE
193.3x
Price in 2029
AU$2.94
MRI Guided Cardiac Ablation Adoption Will Transform Long Term Prospects For This Undervalued Player
Catalysts About Imricor Medical Systems Imricor Medical Systems develops MRI compatible cardiac ablation systems intended to enable electrophysiology procedures inside the MRI suite. What are the underlying business or industry changes driving this perspective?Read more
4
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AU$2.7
24.8% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
265.65% p.a.
Profit Margin
9.16%
Future PE
277.62x
Price in 2029
AU$4.14
MRI Electrophysiology Adoption And Aging Demographics Will Drive Long Term Earnings Potential
Catalysts About Imricor Medical Systems Imricor Medical Systems develops MRI compatible cardiac ablation systems that enable interventional electrophysiology procedures to be performed inside the MRI suite. What are the underlying business or industry changes driving this perspective?Read more
32
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AU$2.14
5.2% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
220.96% p.a.
Profit Margin
9.58%
Future PE
294.4x
Price in 2028
AU$1.98
Trending Discussion
Recently Updated Narratives
AN
MRI Electrophysiology Adoption And Regulatory Progress Will Support A Fair Outlook
Fair Value: AU$1.91 6.1% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
MRI Guided Cardiac Ablation Adoption Will Transform Long Term Prospects For This Undervalued Player
Fair Value: AU$2.7 24.8% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
MRI Electrophysiology Adoption And Aging Demographics Will Drive Long Term Earnings Potential
Fair Value: AU$2.14 5.2% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Imricor Medical Systems, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.079
- -695.68%
- -8,661.57%
- 217.1%
About IMR
- Founded
- 2006
- Employees
- n/a
- CEO
- WebsiteView website
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
